The growth of the enzyme immunoassays market is fueled by factors like expanding use of immunoassay tests in cancer, point-of-care in vitro diagnostics, infectious disease testing, therapeutic drug level monitoring, and introduction of novel biomarkers. The long shelf life and ease of use also contributes to the rising acceptance of the ELISA technology in both the academics sector as well as the industry sector. However, the tight R&D budget of pharmaceutical companies, reimbursement challenges, and stringent regulatory approvals are factors that restrain the growth of the enzyme immunoassays market. The introduction of multiple platforms and automated closed systems can also pose as threats to the future of enzyme-linked immunoassays.
The report “Asian Enzyme immunoassays (EIA) Market” analyzes the market by three segments such as instruments, reagents and applications.
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market.
The report also provides an extensive competitive landscaping of companies operating in this market. Key players in the enzyme immunoassays market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux (France), Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany) & others.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
- Unmet needs, revenue pockets and potential areas for expansion
- Comprehensive review of key component providers, assay providers, sole service providers, complete solution providers
Current and Emerging Products
- Analysis of current and emerging Enzyme Immunoassays (EIA) and immunodiagnostic tests
- Review of current instrumentation technologies
- Pricing trend of New high value Immunoassay tests
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
North America Immunoassay
The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Asian immunoassay market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of the Asian immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018. The report “Asian Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.